These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 31400225)
1. A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens. Abraham A; Ostroff G; Levitz SM; Oyston PCF Clin Exp Immunol; 2019 Nov; 198(2):143-152. PubMed ID: 31400225 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model. Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073 [TBL] [Abstract][Full Text] [Related]
10. Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia. Jia Q; Bowen R; Dillon BJ; Masleša-Galić S; Chang BT; Kaidi AC; Horwitz MA Sci Rep; 2018 May; 8(1):7009. PubMed ID: 29725025 [TBL] [Abstract][Full Text] [Related]
11. Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Elkins KL; Cowley SC; Bosio CM Microbes Infect; 2003 Feb; 5(2):135-42. PubMed ID: 12650771 [TBL] [Abstract][Full Text] [Related]
12. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis. Shen H; Chen W; Conlan JW Microb Pathog; 2004 Aug; 37(2):107-10. PubMed ID: 15312850 [TBL] [Abstract][Full Text] [Related]
13. Progress, challenges, and opportunities in Francisella vaccine development. Elkins KL; Kurtz SL; De Pascalis R Expert Rev Vaccines; 2016 Sep; 15(9):1183-96. PubMed ID: 27010448 [TBL] [Abstract][Full Text] [Related]
18. Virulence determinants and protective antigens of Francisella tularensis. Sjöstedt A Curr Opin Microbiol; 2003 Feb; 6(1):66-71. PubMed ID: 12615222 [TBL] [Abstract][Full Text] [Related]
19. Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System. Banik S; Mansour AA; Suresh RV; Wykoff-Clary S; Malik M; McCormick AA; Bakshi CS PLoS One; 2015; 10(6):e0130858. PubMed ID: 26098553 [TBL] [Abstract][Full Text] [Related]
20. Vaccines against Francisella tularensis. Wayne Conlan J; Oyston PC Ann N Y Acad Sci; 2007 Jun; 1105():325-50. PubMed ID: 17395730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]